KU135, a Novel Novobiocin-Derived C-Terminal Inhibitor of the 90-kDa Heat Shock Protein, Exerts Potent Antiproliferative Effects in Human Leukemic Cells

Shary N. Shelton(University of Kansas Medical Center), John D. Robertson(University of Kansas)
Molecular Pharmacology
September 10, 2009
Cited by 96


Related Papers